KORU Medical Systems, Inc. (NASDAQ:KRMD – Free Report) – Analysts at B. Riley boosted their FY2024 EPS estimates for shares of KORU Medical Systems in a research report issued on Tuesday, January 14th. B. Riley analyst K. Bauser now forecasts that the company will earn ($0.13) per share for the year, up from their prior estimate of ($0.14). The consensus estimate for KORU Medical Systems’ current full-year earnings is ($0.14) per share. B. Riley also issued estimates for KORU Medical Systems’ Q4 2024 earnings at ($0.03) EPS, Q4 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.09) EPS.
Other equities research analysts have also issued reports about the stock. Canaccord Genuity Group lifted their target price on shares of KORU Medical Systems from $3.00 to $4.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. Piper Sandler increased their price objective on KORU Medical Systems from $3.00 to $3.50 and gave the company an “overweight” rating in a research report on Thursday, November 14th. Lake Street Capital increased their price target on shares of KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a research report on Tuesday. Finally, Craig Hallum boosted their price objective on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Four equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $4.30.
KORU Medical Systems Stock Performance
NASDAQ:KRMD opened at $4.00 on Thursday. KORU Medical Systems has a twelve month low of $1.98 and a twelve month high of $4.60. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. The stock has a market cap of $183.36 million, a P/E ratio of -16.00 and a beta of 0.45. The business’s 50-day moving average price is $3.77 and its two-hundred day moving average price is $2.95.
Hedge Funds Weigh In On KORU Medical Systems
A number of hedge funds have recently modified their holdings of KRMD. XTX Topco Ltd bought a new stake in shares of KORU Medical Systems in the third quarter worth about $34,000. Connor Clark & Lunn Investment Management Ltd. lifted its position in KORU Medical Systems by 77.7% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock valued at $168,000 after acquiring an additional 26,860 shares during the period. Geode Capital Management LLC grew its stake in shares of KORU Medical Systems by 6.5% in the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock worth $1,262,000 after buying an additional 28,323 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of KORU Medical Systems in the second quarter worth $107,000. Finally, Empire Financial Management Company LLC bought a new stake in KORU Medical Systems during the 3rd quarter valued at about $259,000. Hedge funds and other institutional investors own 58.60% of the company’s stock.
About KORU Medical Systems
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
Read More
- Five stocks we like better than KORU Medical Systems
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- What Investors Need to Know to Beat the Market
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.